Biotech Today
  • Privacy Policy
  • Disclaimer
  • Biotech
  • Markets
  • Bio Space
  • Global News

All Posts in "Global News"

Chinese Exports Decline 21 Percent in February

Chinese Exports Decline 21 Percent in February

Experts attribute the dramatic drop partly to the tariffs the U.S. imposed on Chinese goods.

News Team by News Team — March 09, 2019 By News Team in Global News
Asian Shares Fall on Doubts Over US-China Trade Deal

Asian Shares Fall on Doubts Over US-China Trade Deal

Asian shares fall on report of Chinese doubts about trade deal with the US.

News Team by News Team — March 08, 2019 By News Team in Global News
Russian Lawmakers Pass Bill to Outlaw Insulting the State

Russian Lawmakers Pass Bill to Outlaw Insulting the State

Critics worry that the state will use the laws to silence critics in the country, which already has severely restricted free speech freedoms.

News Team by News Team — March 08, 2019 By News Team in Global News
North Korea Escalates Rhetoric Following Reports of New Nuclear Activity

North Korea Escalates Rhetoric Following Reports of New Nuclear Activity

Despite President Donald Trump’s compromises, Pyongyang says new U.S.-South Korean military activity poses “an open challenge” to it.

News Team by News Team — March 08, 2019 By News Team in Global News
Winter Rain in Greenland Speeds Up Melting of Ice Sheet

Winter Rain in Greenland Speeds Up Melting of Ice Sheet

Researchers were surprised by the number of rain instances in the winter.

News Team by News Team — March 08, 2019 By News Team in Global News
Australia Confronts Its ‘Pacific Solution’

Australia Confronts Its ‘Pacific Solution’

The country’s contentious policy for asylum-seekers may face reform as the public learns more about the offshore detentions.

News Team by News Team — March 07, 2019 By News Team in Global News
The Latest: Lawyer Alleges Anti-Ghosn ‘Plot’ Within Nissan

The Latest: Lawyer Alleges Anti-Ghosn ‘Plot’ Within Nissan

A French lawyer for former Nissan chairman Carlos Ghosn has blamed his client’s troubles on a “plot against him” within Nissan for trying to draw the Japanese automaker closer to French vehicle maker Renault.

News Team by News Team — March 07, 2019 By News Team in Global News
Wolves to lose protections

Wolves to lose protections

U.S. wildlife officials plan to lift protections for grey wolves across the Lower 48 states, re-igniting the legal battle over a predator that’s running into conflicts with farmers and ranchers as its numbers rebound in some regions.

News Team by News Team — March 07, 2019 By News Team in Global News
Huawei sues US over government ban on its products

Huawei sues US over government ban on its products

Chinese company files lawsuit claiming restriction is unlawful, harms consumers and violates constitution

News Team by News Team — March 07, 2019 By News Team in Global News
Asian Shares Mostly Higher, Led by Chinese Markets

Asian Shares Mostly Higher, Led by Chinese Markets

Asian markets mostly higher, led by Chinese shares as officials promise to open economy further.

News Team by News Team — March 06, 2019 By News Team in Global News

Posts pagination

Previous 1 … 190 191 192 … 263 Next
  • Common arthritis pill repurposed to boost hair regrowth in alopecia patientsCommon arthritis pill repurposed to boost hair regrowth in alopecia patients
  • Experimental pill targets nerve pain pathway, cutting opioid use after abdominal surgeryExperimental pill targets nerve pain pathway, cutting opioid use after abdominal surgery
  • AI learns to spot tomato diseases using nearly 9,000 field imagesAI learns to spot tomato diseases using nearly 9,000 field images
  • Locust neurons detect PFAS at environmentally relevant levels, pointing to portable sensorsLocust neurons detect PFAS at environmentally relevant levels, pointing to portable sensors
  • EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD raceEyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race
  • Summit, Akeso’s China approval celebration cut short as survival benefit degradesSummit, Akeso’s China approval celebration cut short as survival benefit degrades
  • New cellular clues to complications of sclerodermaNew cellular clues to complications of scleroderma
  • Fast-spreading malaria parasite mutations in Uganda may weaken Africa’s most widely used malaria therapyFast-spreading malaria parasite mutations in Uganda may weaken Africa’s most widely used malaria therapy
  • Nature has spent billions of years fighting bacteria. AI could help us learn its secretsNature has spent billions of years fighting bacteria. AI could help us learn its secrets
  • Gene-edited beagles produce no detectable major dog allergen, early tests findGene-edited beagles produce no detectable major dog allergen, early tests find

Newsletter

Advertisement

Market Data by TradingView

Popular Posts

  • Common arthritis pill repurposed to boost hair regrowth in alopecia patientsCommon arthritis pill repurposed to boost hair regrowth in alopecia patients
  • Stock-market investors should brace for a weaker dollar, says Goldman SachsStock-market investors should brace for a weaker dollar, says Goldman Sachs
  • Investors betting defensive stock market plays will win as they sold tech, financialsInvestors betting defensive stock market plays will win as they sold tech, financials
  • Next Windows 10 update nearing completion as it gets its official nameNext Windows 10 update nearing completion as it gets its official name

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. biotech-today.com is a wholly-owned subsidiary of Maynard Communication Limited.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

ABOUT US

Biotech Todayr

    Biotech Today shares news and information from biotechnology space. We focus on news, trending companies, leading technology, breakthroughs, and breaking topics as they happen.

Trending Now

  • Vaccine Breakthroughs Stemming from 2020 Crisis Could Treat MORE Than Just Covid-19, Creating Major Opportunity for InvestorsVaccine Breakthroughs Stemming from 2020 Crisis Could Treat MORE Than Just Covid-19, Creating Major Opportunity for Investors
  • QuestCap Inc. – The Social Impact Investment Company Targeting Pandemic Response Technologies and TherapiesQuestCap Inc. – The Social Impact Investment Company Targeting Pandemic Response Technologies and Therapies
  • Is This A Digital HealthTech Giant In The Making?

Subscribe and Follow

Contact Us

    • Biotech Today

 

  • info@maynardcom.com
  • www.biotech-today.com
© 2026 Biotech-Today.com All Rights Reserved | Privacy Policy
Scroll Up